EUVIMEDEUVIMED entdecken
Crossref

Targeted delivery of hybrid nanovesicles for enhanced brain penetration to achieve synergistic therapy of glioma

Ruoning Wang, Xue Wang, Huacong Zhao, Nengjin Li, Jiale Li, Hanwen Zhang, Liuqing Di

Journal of Controlled Release · 2024-01 · 365 · 331-347

DOI: 10.1016/j.jconrel.2023.11.033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2024-01. Verfasst von Ruoning Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; Jiangsu Provincial TCM Engineering Technology Research Center of H…. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma, Nanoparticles, Peptides. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Blood-brain barrier (BBB) obstructing brain drug delivery severely hampers the therapeutic efficacy towards glioma. An efficient brain delivery strategy is of paramount importance for the treatment of glioma. Inspired by brain targeting exosome, biomimetic BBB penetrated hybrid (pHybrid) nanovesicles, engineered by membrane fusion between blood exosome and tLyp-1 peptide modified liposome, is explored for brain targeting drug delivery. Transferrin receptor (TfR) on pHybrid nanovesicles facilitates the BBB transcytosis into brain parenchyma, and eventually endocytosed by glioma cells and diffusion to extra-vascular tumor tissues under the guidance of tLyp-1 peptide. pHybrid nanovesicles co-loaded with salvianolic acid B (SAB) and cryptotanshinone (CPT), which is constructed by membrane hybridization of blood exosome loaded with SAB and tLyp-1 modified liposome loaded with CPT, are explored for cytotoxic and anti-angiogenetic therapy towards glioma. Upon accumulation at tumor site, the loaded CPT and SAB shows synergistic effects towards glioma from cytotoxicity on cancer cells and anti-angiogenesis on tumor, respectively. Overall, this study provides a biomimetic nanoplatform for increased BBB transcytosis into brain parenchyma, which serves as a prospective strategy for delivering therapeutic agents against glioma through synergistic mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGliomaNanoparticlesPeptidesHumansLiposomesCell Line, TumorBrainDrug Delivery SystemsBlood-Brain Barrier

Stichwörter der Autor:innen

Blood exosomeBlood-brain barrier transcytosisCryptotanshinoneHybrid nanovesiclesSalvianolic acid BTargeted delivery

Substanzen

tLyP-1 peptideLiposomesPeptides

Autor:innen und Institutionen

  • School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; Jiangsu Provincial TCM Engineering Technology Research Center of High Efficient Drug Delivery System, Nanjing 210023, China. Electronic…
  • School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China; Jiangsu Provincial TCM Engineering Technology Research Center of High Efficient Drug Delivery System, Nanjing 210023, China.

Zitieren

APA

Wang, R., Wang, X., Zhao, H., Li, N., Li, J., Zhang, H., & Di, L. (2024). Targeted delivery of hybrid nanovesicles for enhanced brain penetration to achieve synergistic therapy of glioma. Journal of Controlled Release, 365, 331-347. https://doi.org/10.1016/j.jconrel.2023.11.033

Vancouver

Wang R, Wang X, Zhao H, Li N, Li J, Zhang H, et al. Targeted delivery of hybrid nanovesicles for enhanced brain penetration to achieve synergistic therapy of glioma. Journal of Controlled Release. 2024;365:331-347. doi:10.1016/j.jconrel.2023.11.033

BibTeX
@article{Wang2024,
  author = {Wang, Ruoning and Wang, Xue and Zhao, Huacong and Li, Nengjin and Li, Jiale and Zhang, Hanwen and Di, Liuqing},
  title = {Targeted delivery of hybrid nanovesicles for enhanced brain penetration to achieve synergistic therapy of glioma},
  journal = {Journal of Controlled Release},
  year = {2024},
  volume = {365},
  pages = {331--347},
  doi = {10.1016/j.jconrel.2023.11.033}
}
Kostenlos starten →